The Global Poultry Probiotic Ingredients Market was valued at USD 126.3 million in 2025 and is estimated to grow at a CAGR of 6.3% to reach USD 230.2 million by 2035.
Poultry probiotic ingredients consist of carefully formulated beneficial microorganisms that support gut health, enhance feed conversion efficiency, strengthen immunity, and improve overall bird performance in commercial operations. These ingredients include strains such as Bacillus, Streptococcus, Bifidobacterium, Lactobacilli, and other probiotic microbes that play critical roles in pathogen suppression, nutrient absorption, digestive optimization, and disease resistance, and serve as natural alternatives to antibiotics. Increasing global poultry production, the rise of antibiotic-free farming practices, and advancements in probiotic technologies are driving growth in this market. Continuous investment in multi-strain formulations, advanced strain development, and performance optimization across different poultry species ensures robust global demand, providing producers with improved gut colonization, stronger pathogen inhibition, enhanced feed conversion ratios, and optimized immune responses across commercial poultry systems.
The lactobacilli segment held a 67.8% share and is expected to grow at a CAGR of 6.2% through 2035. Its dominance stems from superior gut colonization, effective pathogen inhibition, and proven performance across broilers, layers, and breeding stock. Lactobacilli support intestinal health through lactic acid production and provide competitive exclusion against harmful bacteria, making them the preferred probiotic strain for commercial poultry operations.
The chickens segment held a 37.7% share and is anticipated to grow at a CAGR of 6.6% through 2035. This is driven by chickens’ overwhelming presence in global poultry production, covering both meat and egg production. The segment benefits from established probiotic protocols, validated research across production stages, and measurable ROI through improved feed conversion, reduced mortality, and increased overall productivity.
U.S. Poultry Probiotic Ingredients Market accounted for USD 31.2 million in 2025. Growth in North America is fueled by strong demand from commercial broiler operations for gut health optimization, multi-strain probiotics for antibiotic-free farming, and integrated layer operations employing advanced probiotic programs to improve production efficiency.
Key players operating in the Global Poultry Probiotic Ingredients Market include Novus International, Novonesis (formerly Chr. Hansen), Biomin Holding GmbH, Evonik Industries AG, Adisseo France SAS, Kemin Industries, Huvepharma AD, International Animal Health Products, Pic-Bio, Inc., Neospark, Lallemand Animal Nutrition, Alltech, and Arm & Hammer Animal Nutrition. Companies in the Poultry Probiotic Ingredients Market strengthen their foothold by investing in research and development for novel strains, multi-strain formulations, and advanced delivery systems. Expanding production capacities, establishing strategic partnerships with feed producers, and entering emerging geographic markets help enhance reach and distribution. Firms also emphasize quality assurance, regulatory compliance, and scientifically validated performance data to build customer trust.
This product will be delivered within 2-4 business days.
Poultry probiotic ingredients consist of carefully formulated beneficial microorganisms that support gut health, enhance feed conversion efficiency, strengthen immunity, and improve overall bird performance in commercial operations. These ingredients include strains such as Bacillus, Streptococcus, Bifidobacterium, Lactobacilli, and other probiotic microbes that play critical roles in pathogen suppression, nutrient absorption, digestive optimization, and disease resistance, and serve as natural alternatives to antibiotics. Increasing global poultry production, the rise of antibiotic-free farming practices, and advancements in probiotic technologies are driving growth in this market. Continuous investment in multi-strain formulations, advanced strain development, and performance optimization across different poultry species ensures robust global demand, providing producers with improved gut colonization, stronger pathogen inhibition, enhanced feed conversion ratios, and optimized immune responses across commercial poultry systems.
The lactobacilli segment held a 67.8% share and is expected to grow at a CAGR of 6.2% through 2035. Its dominance stems from superior gut colonization, effective pathogen inhibition, and proven performance across broilers, layers, and breeding stock. Lactobacilli support intestinal health through lactic acid production and provide competitive exclusion against harmful bacteria, making them the preferred probiotic strain for commercial poultry operations.
The chickens segment held a 37.7% share and is anticipated to grow at a CAGR of 6.6% through 2035. This is driven by chickens’ overwhelming presence in global poultry production, covering both meat and egg production. The segment benefits from established probiotic protocols, validated research across production stages, and measurable ROI through improved feed conversion, reduced mortality, and increased overall productivity.
U.S. Poultry Probiotic Ingredients Market accounted for USD 31.2 million in 2025. Growth in North America is fueled by strong demand from commercial broiler operations for gut health optimization, multi-strain probiotics for antibiotic-free farming, and integrated layer operations employing advanced probiotic programs to improve production efficiency.
Key players operating in the Global Poultry Probiotic Ingredients Market include Novus International, Novonesis (formerly Chr. Hansen), Biomin Holding GmbH, Evonik Industries AG, Adisseo France SAS, Kemin Industries, Huvepharma AD, International Animal Health Products, Pic-Bio, Inc., Neospark, Lallemand Animal Nutrition, Alltech, and Arm & Hammer Animal Nutrition. Companies in the Poultry Probiotic Ingredients Market strengthen their foothold by investing in research and development for novel strains, multi-strain formulations, and advanced delivery systems. Expanding production capacities, establishing strategic partnerships with feed producers, and entering emerging geographic markets help enhance reach and distribution. Firms also emphasize quality assurance, regulatory compliance, and scientifically validated performance data to build customer trust.
Comprehensive Market Analysis and Forecast
- Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
- Competitive landscape with Porter’s Five Forces and PESTEL analysis
- Market size, segmentation, and regional forecasts
- In-depth company profiles, business strategies, financial insights, and SWOT analysis
This product will be delivered within 2-4 business days.
Table of Contents
Chapter 1 Methodology & Scope
Chapter 2 Executive Summary
Chapter 3 Industry Insights
Chapter 4 Competitive Landscape, 2025
Chapter 5 Market Estimates and Forecast, by Product, 2022-2035 (USD Million) (Kilo Tons)
Chapter 6 Market Estimates and Forecast, by Application, 2022-2035 (USD Million) (Kilo Tons)
Chapter 7 Market Estimates and Forecast, by Region, 2022-2035 (USD Million) (Kilo Tons)
Chapter 8 Company Profiles
Companies Mentioned
The companies profiled in this Poultry Probiotic Ingredients market report include:- Novonesis (formerly Chr. Hansen)
- Novus International
- Biomin Holding GmbH
- Evonik Industries AG
- Adisseo France SAS
- Huvepharma AD
- Kemin Industries
- International Animal Health Products
- Pic-Bio, Inc.
- Neospark
- Lallemand Animal Nutrition
- Alltech
- Arm & Hammer Animal Nutrition
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 210 |
| Published | January 2026 |
| Forecast Period | 2025 - 2035 |
| Estimated Market Value ( USD | $ 126.3 Million |
| Forecasted Market Value ( USD | $ 230.2 Million |
| Compound Annual Growth Rate | 6.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 14 |
